Drug intelligence / Profile preview

Spirulysat

Development stage
Preclinical
Lead developer
Algosource
Modality
Recombinant Proteins and Enzymes
Administration
Oral
01

Overview

Spirulysat is a liquid dietary supplement developed by the French company AlgoSource. It is an aqueous extract derived from fresh spirulina (*Arthrospira platensis*) using a patented cold-water extraction process that avoids solvents and chemicals. The primary active component is phycocyanin, a blue pigment-protein complex known for its potent antioxidant properties. Unlike dried spirulina products, Spirulysat is provided in a liquid form, which is reported to enhance the bioavailability and antioxidant efficacy of the phycocyanin. It is primarily marketed for general wellbeing and antioxidant support, although AlgoSource has also investigated its potential applications in cardiovascular health (atherosclerosis prevention), liver protection (NAFLD/NASH), and supportive care in oncology through clinical studies conducted with French research institutions.

Brand names
Spirulysat
Other names
phycocyaninespirulina extractphycocyanine/spirulina extracts

Beyond the preview

Go deeper on Spirulysat.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spirulysat.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call